T 2106/10 (Tenascin binding to fibronectin/Novartis Forschungsstiftung) of 04.02.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T210610.20140204
- Date of decision
- 4 February 2014
- Case number
- T 2106/10
- Petition for review of
- -
- Application number
- 02776926.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
- Applicant name
- Novartis Forschungsstiftung, Zweigniederlassung
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 101(3)(a)European Patent Convention Art 111(1)European Patent Convention Art 84
- Keywords
- Reimbursement of appeal fee - (no)
Claims - clarity
Claims - main request (no)
Claims - clarity
Claims - auxiliary request (no) - Catchword
- -
- Citing cases
- T 0595/15
Order
For these reasons it is decided that:
The appeal is dismissed.
The request for reimbursement of the appeal fee
according to Rule 103(1)(a) EPC is rejected.